0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

OBSERVATIONS ON TWENTY-EIGHT PATIENTS TREATED WITH THE EHRLICH-HATA REMEDY (SALVARSAN)

B. C. CORBUS, M.D.
JAMA. 1911;LVI(8):566-573. doi:10.1001/jama.1911.02560080014004.
Text Size: A A A
Published online

Notwithstanding the fact that Ehrlich says that the preliminary stage has been closed, one receives the impression from the recent literature on 606 that there are many points still to be settled in almost every phase of the work with this new remedy especially in regard to its administration, prognosis, indications and by-effects. We stand at the beginning of our work; many questions need elucidation, and it is of general interest that results should be collected from many different sources.

The difficulty of following the technic according to the directions enclosed with salvarsan is apparent, for here one is told vaguely to use an intravenous method, a neutral suspension or an alkaline solution. At the present writing, the intravenous and the alkaline solution methods are the most popular in European clinics, but still each clinician is endeavoring to push his own method regardless of whether or not the other method

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();